Cite

HARVARD Citation

    Joseph, J. et al. (2019). Guillain-Barre syndrome observed with adoptive transfer of lymphocytes genetically engineered with an NY-ESO-1 reactive T-cell receptor. Journal for immunotherapy of cancer. 7 (1), p. . [Online]. 
  
Back to record